reference/35260662

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35260662

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	50
issn	0022-2828
pageRange	36-50
publicationName	Journal of Molecular and Cellular Cardiology
startingPage	36
bibliographicCitation	Fujii S, Kobayashi S, Chang Y, Nawata J, Yoshitomi R, Tanaka S, Kohno M, Nakamura Y, Ishiguchi H, Suetomi T, Uchinoumi H, Oda T, Okuda S, Okamura T, Yamamoto T, Yano M. RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure. Journal of Molecular and Cellular Cardiology. 2023 May;178():36–50. doi: 10.1016/j.yjmcc.2023.03.007.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd1d3c576583bab26c3993e7ed7b828e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6c77509798b78be8f8e11027061fd9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68580d0c75f6106e1f56f655f49b355e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d54d9e61d8c98276ce7982f39c9d1582 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60872f9fbbd7e5db7c9fb7302d56e7d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a52e899e735a0f5a8788588ffe51b1e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8be8b929b40777df2ae04589277f9320 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_176eba481ac257844f35124305d7f5b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c33b2bbd8f2efd8ec58cce0581764ff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_934858eeed99008de4b4d157a39e7fa8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1668965e47bec9618ee5a0796212ef0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaa50a6f2db77e2bfee56e984f20508b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4f93afd12bf0d8b065ea18ad8977780 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_530ec5b661e6a41990aa80299f0e68b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_682cb7817a815a5725d2fd6cb1509c40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e73925fbf4a5214f39004b642c12d67
date	202305
identifier	https://pubmed.ncbi.nlm.nih.gov/36963751 https://doi.org/10.1016/j.yjmcc.2023.03.007
isPartOf	https://portal.issn.org/resource/ISSN/0022-2828 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4968
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure
discusses	http://id.nlm.nih.gov/mesh/M0005658 http://id.nlm.nih.gov/mesh/M0003213 http://id.nlm.nih.gov/mesh/M0029444
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006333Q000378 http://id.nlm.nih.gov/mesh/D017180Q000209 http://id.nlm.nih.gov/mesh/D017180Q000235 http://id.nlm.nih.gov/mesh/D006333Q000188 http://id.nlm.nih.gov/mesh/D006333Q000209 http://id.nlm.nih.gov/mesh/D009203Q000188 http://id.nlm.nih.gov/mesh/D009203Q000378 http://id.nlm.nih.gov/mesh/D009203Q000150
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D002147Q000378 http://id.nlm.nih.gov/mesh/D032383Q000378 http://id.nlm.nih.gov/mesh/D003620Q000494 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D020257 http://id.nlm.nih.gov/mesh/D019837Q000378 http://id.nlm.nih.gov/mesh/D001145Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6914273 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d9a5fbc3d2e1a4b9782d5cc136cd560a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2952 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7922 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9988 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5378825 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10522 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8166

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20191

Total number of triples: 62.